阿片类可以通过抑制相邻的抑制性内部神经元来激发海马金字塔神经元
概括
片类药物通过抑制GABAergic内部神经元来间接激发海马体的金字塔细胞. 这种机制可以解释成性药物效应,并且可以被纳洛或比库库林阻.
科学领域:
- 神经科学是一个神经科学.
- 神经药理学神经药理学
- 细胞电生理学 细胞电生理学
背景情况:
- 阿片类药物和阿片类具有非典型的激发海马金字塔细胞.
- 了解这种兴奋的精确机制对于理解药物成至关重要.
- 以前的研究表明直接影响,但间接机制仍未被探索.
研究的目的:
- 阐明阿片类药物激发海马金字塔神经元的间接机制.
- 调查抑制性内神经元在调解阿片类药物的作用中的作用.
- 探索这些发现与药物成的电图标志的潜在相关性.
主要方法:
- 纳洛,比库库林和离子的离子化以对抗激发.
- 逆侧海马体的超体刺激,以唤起复发性抑制.
- 来自海马体金字塔细胞的电生理记录.
主要成果:
- 由阿片类药物诱导的金字塔细胞激发被纳洛,比库库林和离子对抗.
- 复发性抑制被恩基法林阻断,被乙胆缩短.
- 片似乎通过抑制附近含有胺黄油酸 (GABA) 的内神经元来激发金字塔神经元.
结论:
- 阿片类药物诱导的海马体金字塔细胞激发是通过抑制GABAergic内部神经元间接介导的.
- 这种间接的抑制机制可能与成性药物使用的电图表现有关.
- 针对这种抑制途径可以为成提供新的治疗策略.
相关概念视频
Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...


